Zeneca declares commitment to inherited disease diagnostics with launch of new test for liver and lung function
This article was originally published in Clinica
Executive Summary
Zeneca Diagnostics has launched the first genetic test that will detect alpha-1-antitrypsin deficiency (AAT), which is associated with adult emphysema and progressive liver cirrhosis in children.